Christopher M Reid1, Bryan Yan2, Wan Azman Wan Ahmad3, Liew Houng Bang4, Sim Kui Hian3, Terrance Chua5, Mark Chan6, John Beltrame7, Stephen J Duffy8, Angela Brennan9, Andrew Ajani10. 1. CCRE Therapeutics, Monash University, Melbourne, Vic, Australia; Melbourne Interventional Group, Vic, Australia. Electronic address: chris.reid@monash.edu. 2. Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong. 3. National Cardiovascular Disease Database Registry of Malaysia, Malaysia; Department of Medicine, University of Malaysia, Malaysia. 4. Department of Medicine, University of Malaysia, Malaysia; Department of Cardiology, Sarawak General Hospital, Faculty of Medicine, University of Malaysia, Sarawak, Malaysia. 5. National Heart Centre, Singapore. 6. National University Heart Centre, Singapore. 7. Coronary Angiography Registry Database of South Australia (CARDOSA) registries, SA, Australia; Department of Medicine, University of Adelaide, SA, Australia. 8. CCRE Therapeutics, Monash University, Melbourne, Vic, Australia. 9. CCRE Therapeutics, Monash University, Melbourne, Vic, Australia; Melbourne Interventional Group, Vic, Australia. 10. Melbourne Interventional Group, Vic, Australia; Coronary Care Unit, Royal Melbourne Hospital, Vic, Australia.
Abstract
BACKGROUND: Clinicians and other stakeholders recognize the need for clinical registries to monitor data in order to improve the outcome and quality of care in the delivery of medical interventions. The establishment of a collaboration across the Asia Pacific Region to inform on variations in patient and procedural characteristics and associated clinical outcomes would enable regional benchmarking of quality. AIMS & METHODS: The aims of the collaboration are a) to identify the characteristics of patients undergoing PCI across the Asia Pacific region, b) to report on outcomes of patients undergoing PCI, c) to develop an appropriate ethnic and region specific risk adjustment model for patients undergoing PCI and d) to establish a registry framework for research, education and training in the area of cardiovascular interventions across the Asia Pacific Region. Descriptive characteristics of patient undergoing PCI over a 12 month period were collated and reported. RESULTS: Representatives from 27 hospitals attended the inaugural meeting with interested parties from Australia, Singapore, Malaysia and Hong Kong. In every country, males predominated PCI activity. Subjects were older and had higher rates of family history of cardiovascular disease in Australia, while Asian subjects had higher rates of diabetes, dyslipidemia and renal failure. STEMI presentation was higher in Australia than in Asia and drug eluting stent use was higher in Asia. Procedural success rates were similar across the region (>95%). CONCLUSIONS: Procedural success was similar across the region despite differing patient characteristics across countries in terms of pre-procedural risk factors and clinical presentation.
BACKGROUND: Clinicians and other stakeholders recognize the need for clinical registries to monitor data in order to improve the outcome and quality of care in the delivery of medical interventions. The establishment of a collaboration across the Asia Pacific Region to inform on variations in patient and procedural characteristics and associated clinical outcomes would enable regional benchmarking of quality. AIMS & METHODS: The aims of the collaboration are a) to identify the characteristics of patients undergoing PCI across the Asia Pacific region, b) to report on outcomes of patients undergoing PCI, c) to develop an appropriate ethnic and region specific risk adjustment model for patients undergoing PCI and d) to establish a registry framework for research, education and training in the area of cardiovascular interventions across the Asia Pacific Region. Descriptive characteristics of patient undergoing PCI over a 12 month period were collated and reported. RESULTS: Representatives from 27 hospitals attended the inaugural meeting with interested parties from Australia, Singapore, Malaysia and Hong Kong. In every country, males predominated PCI activity. Subjects were older and had higher rates of family history of cardiovascular disease in Australia, while Asian subjects had higher rates of diabetes, dyslipidemia and renal failure. STEMI presentation was higher in Australia than in Asia and drug eluting stent use was higher in Asia. Procedural success rates were similar across the region (>95%). CONCLUSIONS: Procedural success was similar across the region despite differing patient characteristics across countries in terms of pre-procedural risk factors and clinical presentation.
Authors: Jieli Tong; Wen Wei Xiang; An Shing Ang; Wen Jun Sim; Kien Hong Quah; David Foo; Paul Jau Lueng Ong; Hee Hwa Ho Journal: J Geriatr Cardiol Date: 2016-10 Impact factor: 3.327
Authors: Hee Hwa Ho; Dasdo Antonius Sinaga; Mohd Kamal Mohd Arshad; Sazzli Kasim; Jin Hyun Lee; Deanna Zhi Lin Khoo; Kwok Kong Loh; Fahim Haider Jafary; Paul Jau Lueng Ong; Simon Soo Siong Lo Journal: Int J Cardiol Heart Vasc Date: 2020-01-23
Authors: Hoa T T Vu; Hung M Pham; Hoai T T Nguyen; Quang N Nguyen; Loi D Do; Ngoc M Pham; Richard Norman; Rachel R Huxley; Crystal M Y Lee; Christopher M Reid Journal: Int J Cardiol Heart Vasc Date: 2020-09-04
Authors: Lung Chan; Chen-Huan Chen; Juey-Jen Hwang; San-Jou Yeh; Kou-Gi Shyu; Ruey-Tay Lin; Yi-Heng Li; Larry Z Liu; Jim Z Li; Wen-Yi Shau; Te-Chang Weng Journal: Int J Gen Med Date: 2016-05-31
Authors: Hoa T T Vu; Hoai T T Nguyen; Hung M Pham; Loi D Do; Quang N Nguyen; Richard Norman; Rachel R Huxley; Ngoc M Pham; Crystal M Y Lee; Christopher M Reid Journal: Glob Heart Date: 2020-04-08